Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Eichmüller SB[au]:

Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape. Eichmüller SB et al. J Natl Cancer Inst. (2017)

A vaccine targeting mutant IDH1 induces antitumour immunity. Schumacher T et al. Nature. (2014)

Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E. Kordaß T et al. Front Immunol. (2018)

Search results

Items: 1 to 50 of 51

1.

A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.

Das K, Eisel D, Vormehr M, Müller-Decker K, Hommertgen A, Jäger D, Zörnig I, Feuerer M, Kopp-Schneider A, Osen W, Eichmüller SB.

BMC Cancer. 2019 Sep 13;19(1):914. doi: 10.1186/s12885-019-6102-6.

2.

Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients.

Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende CC, Dyckhoff G, Boscolo-Rizzo P, Ezić J, Marienfeld R, Möller P, Kraus JM, Völkel G, Kestler HA, Brunner C, Schuler PJ, Wigand MC, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Waterboer T, Butt J.

Clin Cancer Res. 2019 Aug 23. pii: clincanres.1490.2019. doi: 10.1158/1078-0432.CCR-19-1490. [Epub ahead of print]

PMID:
31444248
3.

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.

Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic J, Marienfeld RB, Möller P, Völkel G, Kraus JM, Kestler HA, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Butt J, Waterboer T, Laban S.

Int J Cancer. 2019 Aug 12. doi: 10.1002/ijc.32623. [Epub ahead of print]

PMID:
31407331
4.

Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype.

Eisel D, Das K, Dickes E, König R, Osen W, Eichmüller SB.

Front Immunol. 2019 Feb 22;10:219. doi: 10.3389/fimmu.2019.00219. eCollection 2019.

5.

Correction: Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system.

Das K, Eisel D, Lenkl C, Goyal A, Diederichs S, Dickes E, Osen W, Eichmüller SB.

PLoS One. 2018 Dec 19;13(12):e0209719. doi: 10.1371/journal.pone.0209719. eCollection 2018.

6.

MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion.

Ast V, Kordaß T, Oswald M, Kolte A, Eisel D, Osen W, Eichmüller SB, Berndt A, König R.

Oncotarget. 2018 Oct 30;9(85):35559-35580. doi: 10.18632/oncotarget.26263. eCollection 2018 Oct 30.

7.

miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro.

Kordaß T, Weber CEM, Eisel D, Pane AA, Osen W, Eichmüller SB.

Oncotarget. 2018 Aug 21;9(65):32507-32522. doi: 10.18632/oncotarget.25986. eCollection 2018 Aug 21.

8.

A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.

Sharbi-Yunger A, Grees M, Cafri G, Bassan D, Eichmüller SB, Tzehoval E, Utikal J, Umansky V, Eisenbach L.

Int J Cancer. 2019 Feb 15;144(4):909-921. doi: 10.1002/ijc.31795. Epub 2018 Dec 5.

PMID:
30106470
9.

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models.

Grees M, Sharbi-Yunger A, Evangelou C, Baumann D, Cafri G, Tzehoval E, Eichmüller SB, Offringa R, Utikal J, Eisenbach L, Umansky V.

Oncoimmunology. 2018 Mar 26;7(7):e1445457. doi: 10.1080/2162402X.2018.1445457. eCollection 2018.

10.

Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial.

Michels J, Becker N, Suciu S, Kaiser I, Benner A, Kosaloglu-Yalcin Z, Agoussi S, Halama N, Pawlita M, Waterboer T, Eichmüller SB, Jäger D, Eggermont AMM, Zörnig I.

Oncoimmunology. 2018 Feb 12;7(6):e1428157. doi: 10.1080/2162402X.2018.1428157. eCollection 2018.

11.

Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E.

Kordaß T, Osen W, Eichmüller SB.

Front Immunol. 2018 Apr 18;9:813. doi: 10.3389/fimmu.2018.00813. eCollection 2018. Review.

12.

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach.

Krackhardt AM, Anliker B, Hildebrandt M, Bachmann M, Eichmüller SB, Nettelbeck DM, Renner M, Uharek L, Willimsky G, Schmitt M, Wels WS, Schüssler-Lenz M.

Cancer Immunol Immunother. 2018 Apr;67(4):513-523. doi: 10.1007/s00262-018-2119-y. Epub 2018 Jan 29. Review.

PMID:
29380009
13.

miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.

Lv N, Hao S, Luo C, Abukiwan A, Hao Y, Gai F, Huang W, Huang L, Xiao X, Eichmüller SB, He D.

Sci China Life Sci. 2018 May;61(5):541-549. doi: 10.1007/s11427-017-9138-9. Epub 2018 Jan 2.

PMID:
29307109
14.

Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.

Eichmüller SB, Osen W, Mandelboim O, Seliger B.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx034. Review.

PMID:
28383653
15.

Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system.

Das K, Eisel D, Lenkl C, Goyal A, Diederichs S, Dickes E, Osen W, Eichmüller SB.

PLoS One. 2017 Mar 16;12(3):e0174077. doi: 10.1371/journal.pone.0174077. eCollection 2017. Erratum in: PLoS One. 2018 Dec 19;13(12):e0209719.

16.

miR-339-3p Is a Tumor Suppressor in Melanoma.

Weber CE, Luo C, Hotz-Wagenblatt A, Gardyan A, Kordaß T, Holland-Letz T, Osen W, Eichmüller SB.

Cancer Res. 2016 Jun 15;76(12):3562-71. doi: 10.1158/0008-5472.CAN-15-2932. Epub 2016 Apr 15.

17.

Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.

Werner S, Chen H, Butt J, Michel A, Knebel P, Holleczek B, Zörnig I, Eichmüller SB, Jäger D, Pawlita M, Waterboer T, Brenner H.

Sci Rep. 2016 May 3;6:25467. doi: 10.1038/srep25467.

18.

SOX5 is involved in balanced MITF regulation in human melanoma cells.

Kordaß T, Weber CE, Oswald M, Ast V, Bernhardt M, Novak D, Utikal J, Eichmüller SB, König R.

BMC Med Genomics. 2016 Feb 29;9:10. doi: 10.1186/s12920-016-0170-0.

19.

Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.

Chen H, Werner S, Butt J, Zörnig I, Knebel P, Michel A, Eichmüller SB, Jäger D, Waterboer T, Pawlita M, Brenner H.

Oncotarget. 2016 Mar 29;7(13):16420-32. doi: 10.18632/oncotarget.7500.

20.

miR-137 inhibits proliferation of melanoma cells by targeting PAK2.

Hao S, Luo C, Abukiwan A, Wang G, He J, Huang L, Weber CE, Lv N, Xiao X, Eichmüller SB, He D.

Exp Dermatol. 2015 Dec;24(12):947-52. doi: 10.1111/exd.12812. Epub 2015 Aug 21.

PMID:
26186482
21.

T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response.

Pfirschke C, Gebhardt C, Zörnig I, Pritsch M, Eichmüller SB, Jäger D, Enk A, Beckhove P.

Cancer Immunol Immunother. 2015 Nov;64(11):1369-81. doi: 10.1007/s00262-015-1739-8. Epub 2015 Jul 10.

PMID:
26160687
22.

LRAT overexpression diminishes intracellular levels of biologically active retinoids and reduces retinoid antitumor efficacy in the murine melanoma B16F10 cell line.

Amann PM, Czaja K, Bazhin AV, Rühl R, Eichmüller SB, Merk HF, Baron JM.

Skin Pharmacol Physiol. 2015;28(4):205-12.

PMID:
25721651
23.

Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice.

Gardyan A, Osen W, Zörnig I, Podola L, Agarwal M, Aulmann S, Ruggiero E, Schmidt M, Halama N, Leuchs B, von Kalle C, Beckhove P, Schneeweiss A, Jäger D, Eichmüller SB.

Int J Cancer. 2015 Jun 1;136(11):2588-97. doi: 10.1002/ijc.29322. Epub 2014 Nov 26.

24.

Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells.

Amann PM, Czaja K, Bazhin AV, Rühl R, Skazik C, Heise R, Marquardt Y, Eichmüller SB, Merk HF, Baron JM.

Exp Dermatol. 2014 Nov;23(11):832-7. doi: 10.1111/exd.12548. Epub 2014 Oct 10.

PMID:
25236354
25.

Estimating the activity of transcription factors by the effect on their target genes.

Schacht T, Oswald M, Eils R, Eichmüller SB, König R.

Bioinformatics. 2014 Sep 1;30(17):i401-7. doi: 10.1093/bioinformatics/btu446.

26.

A vaccine targeting mutant IDH1 induces antitumour immunity.

Schumacher T, Bunse L, Pusch S, Sahm F, Wiestler B, Quandt J, Menn O, Osswald M, Oezen I, Ott M, Keil M, Balß J, Rauschenbach K, Grabowska AK, Vogler I, Diekmann J, Trautwein N, Eichmüller SB, Okun J, Stevanović S, Riemer AB, Sahin U, Friese MA, Beckhove P, von Deimling A, Wick W, Platten M.

Nature. 2014 Aug 21;512(7514):324-7. doi: 10.1038/nature13387. Epub 2014 Jun 25.

PMID:
25043048
27.

Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.

Zörnig I, Halama N, Lorenzo Bermejo J, Ziegelmeier C, Dickes E, Migdoll A, Kaiser I, Waterboer T, Pawlita M, Grabe N, Ugurel S, Schadendorf D, Falk C, Eichmüller SB, Jäger D.

Int J Cancer. 2015 Jan 1;136(1):138-51. doi: 10.1002/ijc.28980. Epub 2014 May 28.

28.

The role of microRNAs in melanoma.

Luo C, Weber CE, Osen W, Bosserhoff AK, Eichmüller SB.

Eur J Cell Biol. 2014 Jan-Feb;93(1-2):11-22. doi: 10.1016/j.ejcb.2014.02.001. Epub 2014 Feb 11. Review.

PMID:
24602414
29.

Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma.

Hassel JC, Amann PM, Schadendorf D, Eichmüller SB, Nagler M, Bazhin AV.

Exp Dermatol. 2013 Nov;22(11):757-9. doi: 10.1111/exd.12236.

PMID:
24433184
30.

MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.

Luo C, Merz PR, Chen Y, Dickes E, Pscherer A, Schadendorf D, Eichmüller SB.

Cancer Lett. 2013 Dec 1;341(2):240-7. doi: 10.1016/j.canlet.2013.08.021. Epub 2013 Aug 17.

PMID:
23962556
31.

Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells.

Simon-Keller K, Paschen A, Hombach AA, Ströbel P, Coindre JM, Eichmüller SB, Vincent A, Gattenlöhner S, Hoppe F, Leuschner I, Stegmaier S, Koscielniak E, Leverkus M, Altieri DC, Abken H, Marx A.

Am J Pathol. 2013 Jun;182(6):2121-31. doi: 10.1016/j.ajpath.2013.02.017. Epub 2013 Apr 2.

32.

miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.

Luo C, Tetteh PW, Merz PR, Dickes E, Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek B, Schadendorf D, Diederichs S, Eichmüller SB.

J Invest Dermatol. 2013 Mar;133(3):768-775. doi: 10.1038/jid.2012.357. Epub 2012 Nov 15.

33.

Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases.

Savchenko MS, Goncharskaia MA, Skorikova EE, Eichmüller SB, Kushlinsky NE, Bazhin AV, Philippov PP.

Oncol Lett. 2012 Feb;3(2):377-382. Epub 2011 Oct 31.

34.

Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells.

Grund SE, Polycarpou-Schwarz M, Luo C, Eichmüller SB, Diederichs S.

Neoplasia. 2012 Mar;14(3):238-48.

35.

MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.

Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, Kool M, Northcott PA, Jugold M, Bazhin AV, Eichmüller SB, Kulozik AE, Pscherer A, Benner A, Taylor MD, Pomeroy SL, Kemkemer R, Witt O, Korshunov A, Lichter P, Pfister SM.

Acta Neuropathol. 2012 Apr;123(4):529-38. doi: 10.1007/s00401-011-0924-x. Epub 2011 Dec 2.

PMID:
22134538
36.

Expression and activity of alcohol and aldehyde dehydrogenases in melanoma cells and in melanocytes.

Amann PM, Hofmann C, Freudenberger M, Holland-Cunz S, Eichmüller SB, Bazhin AV.

J Cell Biochem. 2012 Mar;113(3):792-9. doi: 10.1002/jcb.23406.

PMID:
22020955
37.

Vitamin A metabolism in benign and malignant melanocytic skin cells: importance of lecithin/retinol acyltransferase and RPE65.

Amann PM, Luo C, Owen RW, Hofmann C, Freudenberger M, Schadendorf D, Eichmüller SB, Bazhin AV.

J Cell Physiol. 2012 Feb;227(2):718-28. doi: 10.1002/jcp.22779.

PMID:
21465477
38.

Regulation of gene expression by retinoids.

Amann PM, Eichmüller SB, Schmidt J, Bazhin AV.

Curr Med Chem. 2011;18(9):1405-12. Review.

PMID:
21366525
39.

Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries.

Osen W, Soltek S, Song M, Leuchs B, Steitz J, Tüting T, Eichmüller SB, Nguyen XD, Schadendorf D, Paschen A.

PLoS One. 2010 Nov 30;5(11):e14137. doi: 10.1371/journal.pone.0014137.

40.

Retinal and retinol are potential regulators of gene expression in the keratinocyte cell line HaCaT.

Amann PM, Schadendorf D, Owen RW, Korn B, Eichmüller SB, Bazhin AV.

Exp Dermatol. 2011 Apr;20(4):373-5. doi: 10.1111/j.1600-0625.2010.01127.x. Epub 2010 Aug 31. Erratum in: Exp Dermatol. 2011 Apr;20(4):375.

PMID:
20812966
41.

cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca(2+) homeostasis in melanoma cells.

Bazhin AV, Tambor V, Dikov B, Philippov PP, Schadendorf D, Eichmüller SB.

Cell Mol Life Sci. 2010 Mar;67(5):817-28. doi: 10.1007/s00018-009-0214-0. Epub 2009 Nov 28.

PMID:
19946729
42.

Detergent fractionation with subsequent subtractive suppression hybridization as a tool for identifying genes coding for plasma membrane proteins.

Lange A, Kistler C, Jutzi TB, Bazhin AV, Klemke CD, Schadendorf D, Eichmüller SB.

Exp Dermatol. 2009 Jun;18(6):527-35. doi: 10.1111/j.1600-0625.2008.00821.x. Epub 2009 Jan 18.

PMID:
19175411
43.

Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.

Bazhin AV, Dalke C, Willner N, Abschütz O, Wildberger HG, Philippov PP, Dummer R, Graw J, de Angelis MH, Schadendorf D, Umansky V, Eichmüller SB.

Int J Cancer. 2009 Jan 1;124(1):140-9. doi: 10.1002/ijc.23909.

44.

Visible light modulates the expression of cancer-retina antigens.

Bazhin AV, Schadendorf D, Owen RW, Zernii EY, Philippov PP, Eichmüller SB.

Mol Cancer Res. 2008 Jan;6(1):110-8. doi: 10.1158/1541-7786.MCR-07-0140. Epub 2008 Jan 9.

45.

Identification of selectively expressed genes and antigens in CTCL.

Hartmann TB, Mattern E, Wiedemann N, van Doorn R, Willemze R, Niikura T, Hildenbrand R, Schadendorf D, Eichmüller SB.

Exp Dermatol. 2008 Apr;17(4):324-34. Epub 2007 Nov 2.

PMID:
17979976
46.

Onconeural versus paraneoplastic antigens?

Eichmüller SB, Bazhin AV.

Curr Med Chem. 2007;14(23):2489-94. Review.

PMID:
17979702
47.

Expression of GAGE family proteins in malignant melanoma.

Bazhin AV, Wiedemann N, Schnölzer M, Schadendorf D, Eichmüller SB.

Cancer Lett. 2007 Jun 28;251(2):258-67. Epub 2006 Dec 27.

PMID:
17194529
48.

Photoreceptor proteins as cancer-retina antigens.

Bazhin AV, Schadendorf D, Willner N, De Smet C, Heinzelmann A, Tikhomirova NK, Umansky V, Philippov PP, Eichmüller SB.

Int J Cancer. 2007 Mar 15;120(6):1268-76.

49.

Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins.

Lee M, Kistler C, Hartmann TB, Li F, Dummer R, Dippel E, Booken N, Klemke CD, Schadendorf D, Eichmüller SB.

Cancer Immunol Immunother. 2007 Jun;56(6):783-95. Epub 2006 Nov 7.

PMID:
17089123
50.

Recoverin as a cancer-retina antigen.

Bazhin AV, Schadendorf D, Philippov PP, Eichmüller SB.

Cancer Immunol Immunother. 2007 Jan;56(1):110-6. Review.

PMID:
16444517

Supplemental Content

Loading ...
Support Center